Introduction
============

Poverty, often defined as a low income, is a main cause of hunger and is correlated with malnutrition and a higher risk of illness and disability ([@b1-ijph-41-8]). Hunger and malnutrition directly or indirectly are responsible for half of deaths worldwide and are one of the major public health problems among the most developing countries including the Middle Eastern countries. According to the latest Food and Agriculture Organization (FAO) statistics, there are 925 million hungry worldwide; 37 million of them live in the Middle East and Africa ([@b2-ijph-41-8]). Hunger not only impresses weight but also impacts high economic costs to developing countries by hindering economic, social and political development, increasing individual susceptibility to disease and decreasing learning ability and work capacity ([@b3-ijph-41-8]). In September 2000, world leaders signed the United Nations Millennium Declaration to fight poverty, hunger, disease, illiteracy, environmental degradation and discrimination against women ([@b4-ijph-41-8]). Following this FAO focused on poverty and hunger reduction through improving agricultural productivity and incomes and promoting better nutritional practices at all levels and programmes that enhance direct and immediate access to food by the neediest ([@b5-ijph-41-8]). Over the past 20 years, prevalence of underweight has decreased by 50% in the Middle East, from 12.8% to 6.3%, prevalence of stunted individuals, from 28.2% to 19.7% and that of the wasted shifted from 5.6% to 4.7%; these statistics show the achievement of the Millennium Development Goals in the Middle East ([@b6-ijph-41-8]). Management of micronutrient deficiencies, also, is an important part of the efforts to combat hunger and malnutrition. Micronutrient deficiency which has adverse effect on health, learning ability, productivity, work capacity and economic development, affects all age groups, especially young children and women in both developed and developing countries. The three most prevalent features of micronutrient malnutrition are iron, iodine and vitamin A deficiencies that not only affect many people but also lead to the burden of disease such as high susceptibility to infection, birth defects, blindness, cognitive losses and premature mortality ([@b7-ijph-41-8]).

This paper reviews the prevalence of iron, iodine and vitamin A deficiencies and the measures taken to combat these nutrient deficiencies in the Middle Eastern countries.

Methods
=======

We conducted a systematic review of all papers published in the Middle Eastern countries between 1985 and 2011. Middle Eastern countries were defined as Islamic Republic of Iran (I.R. Iran), Jordan, Iraq, United Arab Emirates, Saudi Arabia, Bahrain, Yemen, Qatar, Turkey, Lebanon, Palestine, Kuwait, Oman, Syria and Egypt.

Electronic databases i.e. PubMed, World Health Organization (WHO), FAO, Flour Fortification Initiative (FFI), Micronutrient Initiative (MI), IranMedex and SID were searched using the terms "poverty", "malnutrition", "iodine deficiency", "iron deficiency", "anemia", "vitamin A deficiency", "salt iodization", "iron fortification" and "hunger", as well as Persian equivalent terms. Once the search has been completed, a total 6057 papers were screened and were retrieved and assessed for relevance based on title and abstract by one reviewer. We included any cross-sectional, longitudinal or review article in English that reported national or regional prevalence of malnutrition, iodine deficiency, iron deficiency, anemia, and vitamin A deficiency and efficacy of fortification programs.

We excluded studies that reported prevalence or association of malnutrition, iodine deficiency, iron deficiency, anemia, and vitamin A deficiency in specific diseases and all case-control, randomized controlled trial, short communication, editorial letter and case reports.

5936 articles were excluded after the title and abstract assessment. Full text of retrieved articles was evaluated by two reviewers and 33 articles that were irrelevant or duplicate were excluded. Finally, 88 were included in this systematic review ([Fig.1](#f1-ijph-41-8){ref-type="fig"}).

Results
=======

### Iron deficiency anemia

Anemia is a public health problem in the most countries, which affects 2 billion (over 30%) worldwide ([@b8-ijph-41-8]). Anemia defines on the basis of blood hemoglobin concentrations and shows the severity of this public health problem among the population; Nutritional deficiency such as iron, folate and vitamin B12 deficiencies, hook worm, malaria, inflammatory diseases and HIV contribute to its development; however, iron deficiency is the primary cause and is responsible for more than 50% of all cases of anemia ([@b9-ijph-41-8]). According to WHO, 47% of children under 5 years old, 30% of non-pregnant women and 42% of pregnant women suffer from anemia ([@b10-ijph-41-8]).

Iron deficiency, the most common nutritional disorder worldwide especially among children, pregnant and non-pregnant women, is one of the risk factors for the global burden of disease in 2000, which caused 841,000 deaths and 35,057,000 disability-adjusted life years (DALYs) lost ([@b11-ijph-41-8]). The main causes of iron deficiency are low intake of heme iron, high intake of non-heme iron, high consumption of phytate and phenolic compounds that inhibit iron absorption, increased requirement and heavy blood losses ([@b7-ijph-41-8], [@b12-ijph-41-8]).

### The prevalence of iron deficiency

Iron deficiency and iron deficiency anemia (IDA) are major public health problems in the Middle Eastern countries ([@b12-ijph-41-8]--[@b14-ijph-41-8]). According to the WHO, the highest number of pre-school children, pregnant and non-pregnant women suffering from IDA live in the Eastern Mediterranean countries includes the Middle East and North Africa ([@b8-ijph-41-8]). The prevalence of IDA among preschool children was 20--67%, among school children was 12.6--50% and among pregnant women was 22.7--54% ([@b14-ijph-41-8]).

In the I.R. Iran the prevalence of iron deficiency and IDA was 31.7% and 19.7--26.2% in 12--15 month old infants, respectively, statistics which are too high ([@b15-ijph-41-8], [@b16-ijph-41-8]). Among children 6--60 months, 43.9% were anemic and 29.1% had IDA. The prevalence of IDA was severe in 12--24 month old children ([@b17-ijph-41-8]). 23.7% of female adolescents and 40.9% of young female adults were iron deficient and 12.2% and 3.8% have IDA, respectively ([@b18-ijph-41-8], [@b19-ijph-41-8]).

In Turkey, 17.2% of population have iron deficiency; 48% of infants, 21--42% of children and 14.7% of adults ([@b20-ijph-41-8]--[@b22-ijph-41-8]). The prevalence of IDA was 3.1% and 13.5% among children 6--16 years old and pregnant women, respectively ([@b23-ijph-41-8], [@b24-ijph-41-8]).

Surveys carried out in Saudi Arabia have reported that iron deficiency was not found among newborns and 3--4 month old infants, whereas the prevalence of iron deficiency had increased significantly and reached to 14.5% among 12--15 month old infants ([@b25-ijph-41-8]). IDA is, also, prevalent among school students, affecting 16.1% of 7--14 year old children and 40.5% of female adolescents (16--18 years old) ([@b26-ijph-41-8]--[@b28-ijph-41-8]). The prevalence of iron deficiency and IDA were not assessed among pregnant and non-pregnant women.

Among Jordanian infants IDA is a severe public health problem ([@b29-ijph-41-8]), with one survey showing 72% of infants had IDA and 57% were iron deficient. Percentage of anemic infants born to anemic mothers was higher than to healthy mothers (81% vs. 65%) ([@b30-ijph-41-8], [@b31-ijph-41-8]). Anemia in pregnancy is a mild- moderate public health, but percentage of pregnant women with IDA has not been assessed ([@b32-ijph-41-8], [@b33-ijph-41-8]). However in one study over 50% of young and pregnant women had symptoms of IDA includes dizziness, fatigue, depression, headache and loss of memory and concentration ([@b34-ijph-41-8]). 28.4% of Jordanian children (5.5--10 years old) had iron deficiency ([@b35-ijph-41-8]).

In the United Arab Emirates, Lebanon and Egypt, iron deficiency and IDA are more prevalent among pregnant women and children ([@b36-ijph-41-8]--[@b40-ijph-41-8]). The prevalence of IDA in the Middle Eastern countries is the same as the prevalence in other developing countries (25--35%), much higher than that of industrialized countries (5--8%). However, in the Middle East data on the prevalence of IDA is limited. Most surveys have assessed anemia rather than IDA and the few surveys that have assessed IDA were provincial, not national ([@b19-ijph-41-8]).

### Iron deficiency-reduction strategies

Iron deficiency contributes to maternal and child mortality, inadequate gestational weight gain, preterm delivery, intra-uterine growth retardation, low birth weight, impaired physical and cognitive development in children, decreased work capacity and productivity in adults and it inhibits economic and social development ([@b8-ijph-41-8], [@b13-ijph-41-8], [@b32-ijph-41-8]); improvement of iron deficiency status can increase individual productivity and national development as much as 20%. WHO has suggested several guidelines includes dietary diversification, food fortification and iron supplement tables in order to prevent and control iron deficiency and IDA worldwide ([@b41-ijph-41-8]). Iron supplementation is a useful approach for short-term when requirements are increased such as during pregnancy, but dietary diversification and food fortification are important long-term strategies ([@b9-ijph-41-8], [@b15-ijph-41-8]). Dietary diversification increases iron bioavailability by more consumption of food with high bioavailability iron such as meat and foods that enhance iron absorption such as citrus fruit and vegetables and low intake of foods that inhibit intestinal iron absorption such as tea, coffee, cola beverages and dairy products. However, if the prevalence of iron deficiency and IDA in children and women is high (IDA\>5%), national or regional food fortification programs should be conducted to decrease the prevalence of iron deficiency.

### Food fortification strategy with iron in the Middle East

The best food for fortification is cereal flour such as wheat and maize flour ([@b10-ijph-41-8], [@b42-ijph-41-8]). Wheat flour fortification with iron is an effective approach to combat iron deficiency, however, the iron compound used and amount of iron added is very important. [Table 1](#t1-ijph-41-8){ref-type="table"} shows suggested iron levels (ppm) for fortification of wheat flour according to the iron compound and daily flour consumption.

High levels of these flours are produce and consumed as breads, pasta, noodles and other products globally. Therefore, iron fortification of flour can improve the iron status of large parts of populations. Flour fortification with iron has played an important role in decreasing iron deficiency in countries such as Canada, U.S. and some countries of Europe; however, it has not been effective as in the most Middle Eastern countries. According to WHO, 44% of wheat flour is fortified with iron in the Eastern Mediterranean countries ([@b43-ijph-41-8]). [Table 2](#t2-ijph-41-8){ref-type="table"} shows kind of food and iron levels that implemented for food fortification in the Middle Eastern countries. In Iran, pilot project of flour fortification (with 60 ppm of elemental iron and 1.5 ppm of folic acid) initiated in Bushehr province in 2001 and six years later has became national program is ongoing ([@b44-ijph-41-8]).

In other Middle Eastern countries, apart from Turkey, also, national or regional flour fortification program with iron has been conducted; however, it is effective only in five countries including Egypt, I.R. Iran, Jordan, Lebanon and Syria iron fortification program. Other countries apply non-recommended, atomized, reduced or hydrogen-reduced iron powders that have no positive effect on iron status ([@b10-ijph-41-8]). Iron fortification program hence need to be revised via changes in the iron compound use to effectively decrease the high prevalence of iron deficiency and IDA in these countries for fortification and levels of iron added. Moreover, hemoglobin is the last indicator of iron deficiency and do not affect by iron fortification in short- and mid-term, therefore other indicators of iron deficiency such as ferritin should be applied to evaluate the effect of iron fortification programs on iron status ([@b45-ijph-41-8]--[@b47-ijph-41-8]). In addition high consumption of dietary components that inhibit iron absorption such as phytate, or low consumption of iron containing foods such as meat, fortified bread and vitamin A deficiency are important factors that can decrease benefits of flour fortification with iron on iron status and anemia ([@b48-ijph-41-8]).

Nevertheless, there is some doubt about the safety of flour fortification with iron that may lead to an iron overload, zinc deficiency or adverse effects in subjects with specific disease or medical conditions. Evaluation results of the flour fortification programs in Busher and Golestan, two provinces of Iran, showed neither adverse effect nor iron overload following fortification of flour with iron ([@b44-ijph-41-8]). However, a recent study in Semnan, a province in Iran, indicated that flour fortification with iron resulted in reduction of antioxidant capacity and enhancement of oxidative stress biomarkers i.e. superoxide dismutase or glutathione peroxidase activity in non-anemic healthy men. Although in this study no symptoms of iron overload were observed but the authors did not support the safety of flour fortification with iron as a population-based strategy to combat iron deficiency and suggested that all kind of flour in the country should not be fortified ([@b49-ijph-41-8]). However, there is an agreement that every public health intervention has advantages for a majority and may have some disadvantages for a minority ([@b44-ijph-41-8]).

Conclusion
==========

Overall, despite of FAO efforts and WHO guidelines in order to combat iron deficiency, it is a public health problem in the Middle Eastern countries due to ineffective iron fortification program, food interaction and hemoglobin application as anemia indictors in countries with successful iron fortification program. Therefore further investigations are needed to reduce the prevalence of iron deficiency and IDA in populations especially at high risk groups.

### Iodine deficiency disorders

Iodine is a micronutrient that plays a role in the synthesis of thyroid hormones, which are fundamental for brain development, growth, and modulation of metabolic rate, thermogenesis and energy ([@b50-ijph-41-8]). Low dietary intake of iodine is the main cause of iodine deficiency ([@b7-ijph-41-8]). Iodine deficiency disorder (IDD), a group of iodine deficiency abnormalities, are a major public health problem worldwide and consist of a spectrum of disorders that range from simple goiter, to hypothyroidism, impaired psychosomatic performance, decreased intelligent quotient and typical cretinism; however, the main consequence of iodine deficiency is impaired development of fetal brain ([@b51-ijph-41-8]), an IDD, which data shows is the most common cause of preventable brain damage in children and which inhibits the social and economic development of countries ([@b52-ijph-41-8],[@b53-ijph-41-8]). Urinary iodine concentration and total goiter rate are the recommended indicators for evaluating iodine status and determining the severity of iodine deficiency in a population ([@b7-ijph-41-8]). According to WHO between 1993 to 2003 a total of 54 countries worldwide suffered from iodine deficiency and 3 billion had insufficient iodine intakes, infants, pregnant and lactating women being among those most affected ([@b54-ijph-41-8]).

### Iodine deficiency-reduction strategies

Over the past years, WHO/International Council for Control of Iodine Deficiency Disorders (ICCIDD)/UNICEF to elimination IDD worldwide used universal salt iodization (USI) which caused significant advances in IDD control ([@b52-ijph-41-8],[@b55-ijph-41-8]). USI, defined as iodization of all salt for human, livestock and agriculture usage, is a cost-effective and endurable method that has been administrated in several countries during the last 60 years ([@b56-ijph-41-8]). However, the latest survey reported that USI trend has decreased during the past decade and 30% of households have no access to iodized salt worldwide ([@b53-ijph-41-8]). There is no legislation for mandatory iodization salt in 30 countries and iodized salt quality and population iodine status are not controlled appropriately in many countries ([@b52-ijph-41-8]). In the most countries of the Middle East iodization of salt is mandatory except for Saudi Arabia and the United Arab Emirates. I.R. Iran, Iraq, Syria, Jordan and Lebanon have the highest household iodized salt usage while Egypt and United Arab Emirates have the lowest ([@b57-ijph-41-8]).

### The prevalence of Iodine deficiency and food fortification strategy with Iodine in the Middle East

Table 3 shows kind of food and iodine levels that implemented for food fortification in the Middle Eastern countries. Before implementation of salt iodization the prevalence of total goiter rate in I.R. Iran was reported to be between 10--60% and two years after mandatory iodization of all salt, in 1996, 95% of households consuming iodized salt; however, goiter was endemic (53.8%) and urinary iodine concentration (UIC) was still high in many cities of Iran because of the short duration of iodized salt usage. However, in 2001, after 7 years, total goiter rates significantly reduced and UIC improved ([@b58-ijph-41-8]). The last national survey was conducted in 2007 in order to monitor the IDD status and stability of salt iodization program findings showed that 98% of households consumed iodized salt and more than 95% consumed sufficient iodized salt. Total goiter rate had significantly reduced and was estimated to be 5.7% ([@b50-ijph-41-8]). National studies documented major measures had been taken to eliminate iodine deficiency in I.R. Iran which had achieved sustained control program for iodine deficiency ([@b59-ijph-41-8],[@b60-ijph-41-8]). Studies reported that iodized salt with 40 ppm potassium iodide per kg of sodium chloride had resulted in acceptable iodine status among Iranian infants, pregnant and lactating women and in decrease in IDD prevalence after mandatory iodization of salt ([@b60-ijph-41-8]--[@b64-ijph-41-8]).

In Turkey household salt was iodized with 50--70 mg/kg potassium iodide or 25--40 mg/kg potassium iodine in 1998 to prevent consequences of iodine deficiency, especially goiter ([@b65-ijph-41-8],[@b66-ijph-41-8]); in 2007, a national study reported 27.8% of Turkish schoolchildren had moderate and severe iodine deficiency, indicating an improvement of iodine status, in comparison to 1997 and 2002 surveys (58% and 38.9%, respectively). This study showed in two thirds of cities survey iodine deficiency has been eliminated, 73.5% of accessible salt were iodized and 56.5% contained sufficient iodine ([@b65-ijph-41-8]). However, iodine deficiency and goiter is still a public health problem in some regions of Turkey, e.g. Isparta, Kayseri and Malatya provinces ([@b67-ijph-41-8]--[@b70-ijph-41-8]). Among pregnant women, also, iodine status is controversial; approximately half the pregnant women are under the WHO/UNICEF/ICCIDD borderline level (UIC = 149.7 vs. 150 μg/L) and 24.8% had goiter; despite 95% of pregnant women using iodized salt, iodine deficiency is a critical problem in this group ([@b71-ijph-41-8]). A recent study reported iodine status as sufficient among adults, 7 years after initiation of mandatory iodization ([@b66-ijph-41-8]).

Despite salt iodization by addition of 30--70 ppm potassium iodide in Egypt, studies have indicated that goiter is endemic and UIC is low still in several regions, which may be due to inadequate iodization of salt or high consumption of goitrogens ([@b72-ijph-41-8]--[@b74-ijph-41-8]). A recent survey in Egyptian children founded that 91.9% of schoolchildren had abnormal UIC and 25% had clinical goiter. Mild and moderate iodine deficiency was observed among 60.6% and 31.3% of children, respectively indicating iodine deficiency to be a public health problem in some areas of Egypt ([@b75-ijph-41-8]).

In 1991, IDD was recognized as a public health problem in Yemen and a salt iodization program was begun in 1995 to control IDD, a strategy which significantly decreased the prevalence and severity of IDD and total goiter rate. Four years after salt iodization initiation, a survey reported that total goiter rate decreased from 32% to 16.8% among schoolchildren, its prevalence being 31.1% and 7.4% in lowland and mountainous regions, respectively. Of schoolchildren, 4.7% and 2.6% has severe IDD in mountain and lowland regions, respectively; however, 70% had no deficiency. Girls had better iodine status than boys. However, because half of Yemeni households do not consume iodized salt may interfere by IDD elimination program ([@b76-ijph-41-8],[@b77-ijph-41-8]).

In Kuwaiti adults, iodine intake was adequate according to WHO report, however, 23% of adults had mild and moderate iodine deficiency; UIC\<100 μg/L, among pregnant women, also, 56.8% had insufficient iodine intakes (UIC\<145 μg/L). In conclusion, results of these two studies suggest the need for a national survey to determine iodine status among the Kuwaiti population ([@b78-ijph-41-8],[@b79-ijph-41-8]). Surveys carried out among schoolchildren in the other Middle Eastern countries, including Saudi Arabia, Bahrain and United Arab Emirates report that there is a mild and moderate iodine deficiency in the countries mentioned; however, it is a major public health problem only in Saudi Arabia (total goiter rate\>5% and UIC\<100 μg/L) ([@b54-ijph-41-8],[@b80-ijph-41-8],[@b81-ijph-41-8]). National surveys are needed regularly in these countries, especially Saudi Arabia and the United Arab Emirates, as there is no legislation for iodization of salt ([@b57-ijph-41-8]).

Conclusion
==========

Overall, surveys carried out have indicated the important role of iodized salt in the prevention IDD in the Middle Eastern countries. Iodization of salt is an useful strategy in Iran and status of IDD currently is under control without any side-effect. It is, also, an effective program to improve IDD in the rest of countries of the region and now severity of IDD is mild (except for Iraq and Saudi Arabia). However, it seems that amount of fortification is not enough to eliminate IDD, therefore further investigations are needed to reduce it.

Vitamin A deficiency
--------------------

Vitamin A is an essential nutrient for growth and differentiation of cells, function of visual, immune and reproduction systems and maintenance of membranes integrity. Poor nutrition, low intake of vitamin A-rich foods and infectious diseases such as diarrhea and measles are the most common cause of vitamin A deficiency (VAD) ([@b7-ijph-41-8]). Infants, young children and pregnant women especially in low-income countries are more susceptible to VAD; it is estimated that 190 million children and 19 million pregnant women worldwide suffer from VAD which leads to night blindness, xerophthalmia, infection, iron deficiency anemia, and mortality in mentioned groups ([@b7-ijph-41-8],[@b82-ijph-41-8]).

### The prevalence of vitamin A deficiency

Vitamin A status and its severity among the population have been evaluated by prevalence of night blindness and retinol concentration in children and pregnant women determination ([@b7-ijph-41-8]). With respect to prevalence of night blindness, VAD is a mild public health problem among preschool children in the all Middle Eastern countries and is a public health problem among pregnant women in Egypt, Iraq, Saudi Arabia, Turkey and Yemen. However, according to the retinol concentration, VAD is mild-to-severe public health problem among preschool children in the most Middle Eastern countries (apart from I.R. Iran) and moderate-to-severe public health problem among pregnant women in the all countries of the Middle East, in 2005 ([@b83-ijph-41-8]). In addition, Egypt, Iraq and Yemen are among countries where vitamin A supplementation is a priority.

### Vitamin A deficiency-reduction strategies

VAD is a major cause of mortality in children under five, and improving its status can enhance resistance to related diseases and decrease mortality rate by 23% ([@b84-ijph-41-8]). The main approaches to combat the VAD include vitamin A supplementation, food diversification and food fortification. The administration of high-dose vitamin A supplements is a short-term and cost-effective strategy that can reduce infection morbidity and mortality in deficient subjects especially children. In Egypt, Iraq and Yemen vitamin A supplementation programs have been implemented since 1999, with successful outcomes in Egypt ([@b84-ijph-41-8],[@b85-ijph-41-8]). The vitamin A supplementation coverage rate (% of children aged 6--59 months) in Egypt was reported at 68% in 2008, 47% in Yemen in 2007 and 0.84 % in Iraq in 2006, by the World Bank ([@b86-ijph-41-8]--[@b88-ijph-41-8]). In contrast, food diversification and food fortification are endurable strategies to fight VAD. Food fortification of basic food items such as sugar, rice, wheat and sodium monoglutamate, have been achieved in some developing countries however it does not conduct as a national or regional program in the Middle Eastern countries ([@b85-ijph-41-8]). Hence the principle strategy for controlling vitamin A deficiency in the Middle East is education of families on vitamin A-rich food selection, coupled with vitamin A supplementation. In addition because breast milk is a good source of vitamin A, encouraging breast feeding is an important strategy to prevent VAD in infants.

Conclusion
==========

Overall, there is mild-to-severe vitamin A deficiency in the Middle Eastern countries, and only Iraq, Egypt and Yemen are among 61 countries with prioritized vitamin A supplementation and poverty-reduction strategies, whereas and in rest of the countries food diversity, vitamin A supplementation and breast feeding are vitamin A-reduction strategies.

Ethical considerations
======================

Ethical issues (Including plagiarism, Informed Consent, misconduct, data fabrication and/or falsification, double publication and/or submission, redundancy, etc) have been completely observed by the authors.

Great thanks to the Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences for the support and providing the facilities for this work. We would like to thank MS N. Shiva for language editing of the manuscript. All authors of the paper have no conflict of interest.

![Flow chart of studies reviewed. Of a total of 6057 articles, 5936 papers were excluded by examining title and abstract. Another 33 articles were excluded after reviewing the whole article and 88 papers left for systematic review](ijph-41-8f1){#f1-ijph-41-8}

###### 

Recommended iron fortification levels (ppm) for wheat flour according to iron compound and daily flour consumption

  **Flour consumption (g/d)**   **NaFeEDTA (ppm)**   **Low extraction wheat flour Ferrous sulfate or ferrous fumarate (ppm)**   **Electrolytic iron power (ppm)**   **High extraction wheat flour NaFeEDTA (ppm)**
  ----------------------------- -------------------- -------------------------------------------------------------------------- ----------------------------------- ------------------------------------------------
  \> 300                        15                   20                                                                         40                                  15
  150--300                      20                   30                                                                         60                                  20
  75--149                       40                   60                                                                         Not recommended                     20
  \< 75                         40                   60                                                                         Not recommended                     40

Reference: Hurrell R, Ranum P, de Pee S, Biebinger R, Hulthen L, Johnson Q, Lynch S (2010). Revised recommendations for iron fortification of wheat flour and an evaluation of the expected impact of current national wheat flour fortification programs. *Food Nutr Bull*, 31, S7--21

###### 

Kind of food and iron levels that implemented to food fortify in the Middle Eastern countries

  **Countries**          **Selected food**   **Iron levels**
  ---------------------- ------------------- -----------------
  Bahrain                Wheat flour         60 ppm
  Egypt                  Wheat flour         30 ppm
  I.R. Iran              Wheat flour         30 ppm
  Iraq                   Wheat flour         30 ppm
  Jordan                 Wheat flour         30--40 ppm
  Kuwait                 Wheat flour         60 ppm
  Lebanon                Wheat flour         30 ppm
  Oman                   Wheat flour         30 ppm
  Qatar                  Wheat flour         60 ppm
  Saudi Arabia           Wheat flour         36.3 ppm
  Syria                  Wheat flour         30 ppm
  Turkey                 Wheat flour         40 ppm
  United Arab Emirates   Wheat flour         30 ppm
  Yemen                  Wheat flour         30 ppm
  Bahrain                \-                  No legislation
  Egypt                  Salt                30--70 ppm
  I.R. Iran              Salt                20--40 ppm
  Iraq                   No data             No data
  Jordan                 Salt                40--60 ppm
  Kuwait                 Salt                80 ppm
  Lebanon                Salt                15--30 ppm
  Oman                   Salt                100--135 mg
  Qatar                  No data             No data
  Saudi Arabia           \-                  No legislation
  Syria                  Salt                18--30 ppm
  Turkey                 Salt                50--70 ppm
  United A.Emirates      \-                  No legislation
  Yemen                  Salt                40 ppm
